Ampicillin: Uses, Dosage, Resistance, Side Effects, and Warnings

Disclaimer

We do not guarantee the accuracy, currency or completeness of information regarding medications or medical products, and official sources should be verified before making any decisions. By using this blog, you agree to assume personal responsibility for relying on the information provided.

This drug commentary is intended for educational and professional reference purposes and does not replace the approved product information, official prescribing information, antimicrobial susceptibility testing, or individualized medical judgment. Ampicillin should be used only when a bacterial infection is proven or strongly suspected to be susceptible to the drug. Current local product labeling should always be checked before prescribing or administering a specific brand or formulation.

---

Summary

Ampicillin is a semi-synthetic, broad-spectrum aminopenicillin and a β-lactam bactericidal antibiotic. It inhibits bacterial cell-wall synthesis by binding to penicillin-binding proteins (PBPs), ultimately producing bacterial cell lysis.

Ampicillin is available in several pharmaceutical forms, including oral capsules, oral suspensions, and parenteral preparations containing ampicillin sodium for intravenous (IV) and/or intramuscular (IM) administration, depending on the specific product.

Its antibacterial spectrum historically includes susceptible Gram-positive and Gram-negative organisms, with particularly important clinical activity against organisms such as Enterococcus spp. and Listeria monocytogenes, in addition to selected streptococci, some Haemophilus influenzae, Escherichia coli, Proteus mirabilis, Salmonella, and Shigella when susceptible.

However, ampicillin is highly vulnerable to many β-lactamases. Resistance is therefore common among several clinically important organisms, particularly penicillinase-producing Staphylococcus aureus and many Gram-negative bacilli. Treatment should therefore be guided by the suspected pathogen, local resistance patterns, and susceptibility testing whenever appropriate.

Ampicillin remains an important targeted antibiotic, particularly in selected infections caused by susceptible organisms and in serious infections such as Listeria monocytogenes meningitis and certain Enterococcus infections.

---

Brand Name

Ampicillin is marketed under multiple brand names and generic product names.

Egyptian-market products identified in the supplied document

The supplied document lists the following Egyptian presentations:

Product	Strength / Form	Manufacturer listed in supplied source
Ampicillin Forte	250 mg/5 mL oral suspension, 60 mL	El Nile
Ampicillin Forte	500 mg, 12 capsules	El Nile
Ampicillin Sodium	1 g vial	CID
Ampicillin Sodium	500 mg IM/IV vial	CID
Ampicillin-Alex	250 mg, 12 capsules	Alexandria
Ampicillin-Alex	500 mg, 12 hard gelatin capsules	Misr / Alexandria
Ampicillin-CID	250 mg, 12 capsules	CID
Ampicillin-CID	500 mg, 12 capsules	CID
Ampicillin-El Nasr	1 g vial	El Nasr
Ampicillin-El Nasr	125 mg/5 mL oral suspension, 30 mL	El Nasr
Ampicillin-El Nasr	250 mg, 12 capsules	El Nasr
Ampicillin-El Nasr	250 mg/5 mL oral suspension, 30 mL	El Nasr
Ampicillin-El Nasr	500 mg, 12 capsules, USP 23	El Nasr
Ampicillin-El Nasr	500 mg vial	El Nasr
Ampicillin-Misr	1 g vial	Misr
Ampicillin-Misr	125 mg/5 mL oral suspension, 60 mL	Misr
Ampicillin-Misr	250 mg, 12 capsules	Misr
Ampicillin-Misr	250 mg vial	Misr
Ampicillin-Misr	250 mg/5 mL oral suspension, 60 mL	Misr
Ampicillin-Misr	500 mg, 12 capsules	Misr
Ampicillin-Misr	500 mg vial	Misr
Ampicillin-Nile	1 g vial	Nile
Ampicillin-Nile	500 mg vial	El Nile
Ampicillin-October Pharma	500 mg, 10 capsules	October Pharma

These presentations and manufacturers are derived from the supplied Egyptian-market document.
Current online Egyptian medicine databases also continue to list products such as Ampicillin Forte, Ampicillin-Alex, Ampicillin-CID, and Ampicillin-October Pharma.

Important: Availability, registration status, packaging, strength, and manufacturer may change. The manufacturer information above reflects the supplied document and publicly available current listings; the Marketing Authorization Holder (MAH) for each individual Egyptian presentation was not independently verified from an official Egyptian regulatory database in the available sources, so it should not be assumed to be identical to the manufacturing company.

---

Category

• Therapeutic class: Antibacterial
• Pharmacological class: Penicillin antibiotic
• Subclass: Aminopenicillin / extended-spectrum penicillin
• Drug class: β-lactam antibiotic
• Mechanism: Bactericidal
• ATC code: J01CA01 — Ampicillin

Ampicillin is classified pharmacologically as an extended-spectrum penicillin.

---

Active Ingredient

Ampicillin

Two principal pharmaceutical forms are encountered:

• Ampicillin anhydrous — generally used in oral formulations.
• Ampicillin sodium — used for parenteral formulations.

The molecular formula of ampicillin is C₁₆H₁₉N₃O₄S, with a molecular weight of approximately 349.4 g/mol for the ampicillin molecule.

---

Pharmaceutical Form & Strength

Oral formulations

The supplied Egyptian information describes:

Capsules

• 250 mg ampicillin anhydrous
• 500 mg ampicillin anhydrous

Oral suspensions

• 125 mg/5 mL
• 250 mg/5 mL

The older supplied composition describes:

• 125 mg/100 mL suspension containing 2.5 g ampicillin anhydrous.
• 250 mg/100 mL suspension containing 5 g ampicillin anhydrous.

The listed excipients in the older formulation include:

• Saccharin sodium
• Sodium citrate
• Sodium benzoate
• Methyl paraben
• Propyl paraben
• Sodium carboxymethylcellulose
• Aerosil 200
• Vanillin
• Dry strawberry flavour
• Cream flavour
• Orange flavour
• Sucrose

The 250 mg/5 mL formulation additionally listed Sunset Yellow.

These excipient lists belong to the older supplied formulation and should not automatically be assumed to apply to every currently marketed Egyptian brand, because excipient composition is product-specific and may change.

Parenteral formulations

The supplied information describes:

• Ampicillin sodium 250 mg vial
• Ampicillin sodium 500 mg vial
• Ampicillin sodium 1 g vial

The stated amounts represent the equivalent quantity of ampicillin anhydrous:

• 250 mg ampicillin sodium equivalent to 250 mg ampicillin
• 500 mg equivalent to 500 mg ampicillin
• 1 g equivalent to 1 g ampicillin

Current professional product information likewise describes ampicillin injection as ampicillin sodium equivalent to the labeled amount of ampicillin.

---

Manufacturer & Marketing Authorization Holder

Because ampicillin is marketed by multiple Egyptian manufacturers, there is no single manufacturer or MAH for the active ingredient as a whole.

The supplied Egyptian-market document identifies the following manufacturers:

• El Nile
• CID
• Alexandria
• El Nasr
• Misr
• Nile
• October Pharma

The supplied document specifically identifies MISR COMPANY FOR PHARMACEUTICAL INDUSTRIES and gives its listed address as:

Belbis Desert Road, KM 4, El Resdom Station, Elkhanka, Abouzaabal, Kalyobia, Egypt.

Telephone and fax information in the old document are also provided, but these historical contact details should not be assumed to remain current.

For a specific Egyptian product, the current package/leaflet and Egyptian regulatory registration record should be used to establish the current manufacturer and Marketing Authorization Holder.

---

Mechanism of Action

Ampicillin is a bactericidal β-lactam antibiotic.

It binds to specific penicillin-binding proteins (PBPs) involved in the final stages of bacterial cell-wall synthesis.

The major pharmacological effect is inhibition of peptidoglycan cross-linking, weakening the bacterial cell wall.

This promotes activation of bacterial autolytic processes and ultimately causes:

Cell-wall disruption → bacterial lysis → bacterial death.

Its activity is therefore time-dependent, with efficacy related primarily to the duration for which free drug concentrations remain above the organism's MIC.

Ampicillin does not directly kill human cells because human cells lack a peptidoglycan cell wall.

---

Spectrum of Activity

Ampicillin has an extended spectrum compared with natural penicillin, but its practical spectrum is strongly limited by acquired resistance.

Important susceptible Gram-positive organisms

Potential activity includes:

• Streptococcus spp.
• Some Enterococcus spp., particularly Enterococcus faecalis when susceptible
• Listeria monocytogenes

Ampicillin remains a key drug for susceptible Listeria monocytogenes infections. CDC guidance identifies IV ampicillin, commonly with gentamicin in non-allergic patients, as standard therapy for listeriosis.

Important Gram-negative organisms

Activity may include susceptible:

• Haemophilus influenzae
• Escherichia coli
• Proteus mirabilis
• Salmonella spp.
• Shigella spp.

However, resistance among these organisms can be substantial and varies geographically.

Important limitations

Ampicillin is generally unreliable against:

• Penicillinase-producing Staphylococcus aureus
• Many contemporary E. coli isolates
• Many other Enterobacterales because of β-lactamase-mediated resistance
• Many other Gram-negative bacilli

Ampicillin therefore should not be selected empirically solely because an organism is historically listed as susceptible.

The supplied older document correctly warned that ampicillin is inactivated by penicillinases and specifically noted substantial historical resistance among S. aureus, E. coli, and H. influenzae.

Practical interpretation

Ampicillin is best regarded as a targeted antibiotic rather than a routine empiric broad-spectrum antibiotic when resistance is likely.

---

Pharmacokinetics

Absorption

Ampicillin is relatively resistant to gastric acid and is absorbed from the gastrointestinal tract, although oral absorption is incomplete.

Food can reduce/interfere with absorption, and traditional product information recommends administration on an empty stomach, commonly at least 30 minutes before meals.

The supplied document reports:

• Peak plasma concentrations approximately 1–2 hours after oral administration.
• Following a 500 mg oral dose, reported peak concentrations approximately 3–6 micrograms/mL.

This is an important distinction from amoxicillin, whose oral absorption is substantially less affected by food. Therefore, instructions for amoxicillin should not automatically be transferred to ampicillin.

Distribution

Ampicillin is widely distributed.

Therapeutic concentrations may occur in:

• Pleural fluid
• Ascitic fluid
• Joint fluid
• Bile and other tissues/fluids

Ampicillin crosses the placenta and small amounts enter breast milk.

CSF penetration is relatively limited under normal circumstances but increases when the meninges are inflamed.

Approximately 20% is protein bound according to the supplied information.

Half-life

The plasma elimination half-life is approximately:

1–2 hours

The supplied document gives approximately 1–1.5 hours, with substantial prolongation possible in:

• Neonates
• Older adults
• Renal impairment

Severe renal impairment can markedly prolong the half-life.

Metabolism

Ampicillin undergoes limited metabolism to penicilloic acid, an inactive metabolite.

Elimination

Renal elimination is the major route.

Ampicillin is cleared by:

• Glomerular filtration
• Renal tubular secretion

Probenecid inhibits tubular secretion, thereby increasing and prolonging ampicillin concentrations.

The supplied document reports that approximately 20–40% of an oral dose may be excreted unchanged in urine within 6 hours, whereas after parenteral administration approximately 60–80% may be excreted in urine within 6 hours. High urinary concentrations are achieved.

Ampicillin is also present in bile and undergoes some enterohepatic recycling.

Hemodialysis can remove ampicillin, making dosage adjustment or supplemental dosing relevant in patients receiving dialysis.

---

Indications

Ampicillin should be used for infections caused by organisms known or strongly suspected to be susceptible.

Potential indications include:

Respiratory infections

• Selected bacterial respiratory tract infections
• Bronchitis when bacterial infection is established and the organism is susceptible
• Selected community-acquired pneumonia when appropriate based on susceptibility and clinical circumstances

ENT infections

• Selected otitis media
• Selected sinus/upper respiratory infections when caused by susceptible organisms

Urinary tract infections

• Susceptible bacterial urinary tract infections

Gastrointestinal infections

• Selected Salmonella and Shigella infections when susceptible

Serious systemic infections

• Bacteremia caused by susceptible organisms
• Selected enterococcal infections
• Selected endocarditis regimens

Listeriosis

• Listeria monocytogenes infection, including invasive disease and meningitis

Meningitis

• Particularly Listeria meningitis, where high-dose IV ampicillin is a key treatment.

The supplied document lists urinary-tract infections, otitis media, sinusitis, oral infections, bronchitis, uncomplicated community-acquired pneumonia, H. influenzae infections, invasive salmonellosis, and listerial meningitis.

Current clinical practice, however, should not treat this historical list as an indication for blind empirical prescribing. Current susceptibility patterns and contemporary guidelines must be considered.

---

Administration

Ampicillin may be administered:

• Orally (PO) — capsules or oral suspension
• Intravenously (IV) — injection or infusion, depending on the product
• Intramuscularly (IM) — for formulations specifically approved for IM use

The exact route depends on the individual marketed formulation.

---

Dosage

Adults — oral

The older supplied information gives:

250 mg–1 g every 6 hours, preferably at least 30 minutes before food.

For urinary-tract infections, the supplied document gives:

500 mg every 8 hours.

However, these are historical product-information dosing instructions and should not be applied indiscriminately to every infection.

Adults — parenteral

The supplied document gives:

500 mg every 4–6 hours by IM or IV injection/infusion for general infections.

For severe infections, considerably higher doses may be required under specialist supervision.

Endocarditis

The supplied source describes:

2 g IV every 6 hours, increased to 2 g every 4 hours in situations such as enterococcal endocarditis or when ampicillin is used alone.

The exact regimen for infective endocarditis should follow the current organism-specific guideline and susceptibility results.

Listerial meningitis

The supplied document gives:

• Adults: 2 g IV every 4 hours for 10–14 days
• Neonates: 50 mg/kg every 6 hours
• Infants 1–3 months: 50–100 mg/kg every 6 hours
• Children 3 months–12 years: 100 mg/kg every 6 hours, maximum 12 g/day

These historical doses should be checked against current neonatal/pediatric and infectious-disease protocols before use.

Renal impairment

Dose and/or dosing interval should be adjusted according to renal function, particularly in severe renal impairment, because ampicillin is predominantly renally eliminated and accumulation increases the risk of toxicity. Current professional labeling explicitly recommends dose adjustment in renal impairment.

---

Method of Preparation

Oral suspension

For a powder-for-suspension product:

1. Follow the specific manufacturer's reconstitution instructions.
2. Add the specified quantity of water to the bottle.
3. Shake thoroughly.
4. Allow foam to settle if necessary.
5. Adjust to the manufacturer's final volume if required.
6. Shake well before each dose.
7. Use the supplied oral syringe or an accurate measuring device.

The exact amount of water and post-reconstitution storage period are product-specific and should be taken from the current package leaflet.

The older supplied document describes bottles of 30, 60, 80, or 100 mL, depending on the presentation.

Injection

Parenteral preparation must follow the specific manufacturer's instructions because the required diluent, final concentration, stability, route, and administration time can differ between products.

For example, a current professional SmPC for ampicillin 500 mg injection specifies reconstitution with 10 mL water for injections and slow administration over approximately 3–4 minutes, with the option of appropriate dilution for infusion.

Therefore, do not assume that the reconstitution volume of one manufacturer's vial applies to another manufacturer's vial.

Ampicillin injection should not be mixed indiscriminately with incompatible solutions or other drugs.

---

Contraindications

Absolute / major contraindication

Known hypersensitivity to ampicillin or another penicillin.

Current product information also requires consideration of serious hypersensitivity to other β-lactam antibiotics, depending on the nature of the previous reaction.

Important clinical avoidance

Ampicillin should generally be avoided when:

• A previous serious immediate β-lactam hypersensitivity reaction has occurred.
• A severe delayed β-lactam reaction is suspected.
• Infectious mononucleosis is suspected, because ampicillin is strongly associated with maculopapular rash in this setting.

Ampicillin should also generally be avoided in suspected acute/chronic lymphoid leukemia when possible because of the high risk of rash.

---

Warnings & Precautions

1. Hypersensitivity and anaphylaxis

Serious and occasionally fatal β-lactam hypersensitivity reactions can occur.

Patients should be questioned regarding previous:

• Penicillin allergy
• Cephalosporin allergy
• Other β-lactam hypersensitivity

Anaphylaxis can occur after either oral or parenteral exposure, although severe reactions are particularly important with parenteral therapy.

2. Ampicillin-associated rash

Maculopapular rashes are relatively common with ampicillin and do not necessarily represent true IgE-mediated penicillin allergy.

This is particularly important in:

• Infectious mononucleosis
• Cytomegalovirus infection
• Lymphoid leukemia

The supplied source specifically emphasizes this distinction.

3. Antimicrobial resistance

Ampicillin should not be used indiscriminately.

The current U.S. label emphasizes antimicrobial stewardship and recommends using ampicillin only for infections that are proven or strongly suspected to be caused by susceptible bacteria.

4. Renal impairment

Use caution and adjust the regimen in renal impairment.

Accumulation can increase the risk of:

• Neurotoxicity
• Seizures
• Other adverse effects

The supplied document particularly warns about high doses in patients with poor renal function.

5. Neurotoxicity

High concentrations, especially in severe renal impairment, may rarely cause:

• Encephalopathy
• Myoclonus
• Seizures

6. Superinfection

Prolonged antibacterial treatment may alter normal flora and promote overgrowth of:

• Resistant organisms
• Clostridioides difficile
• Candida

The supplied source specifically highlights antibiotic-associated colitis and Candida overgrowth.

7. Hematological monitoring

During prolonged or high-dose therapy, monitoring may be appropriate for:

• CBC
• Renal function
• Hepatic status when clinically indicated

The supplied information specifically recommends renal, hepatic, and hematological monitoring during prolonged/high-dose treatment.

8. Diagnostic laboratory interference

Penicillins can interfere with certain laboratory tests, including:

• Some urine glucose tests using copper reduction methods
• Direct antiglobulin (Coombs) testing
• Some urine/serum protein assays
• Certain microbiological tests

The supplied document specifically mentions the Guthrie test for phenylketonuria using Bacillus subtilis.

9. Skin sensitization

Repeated skin contact with penicillins should be avoided because occupational sensitization can occur.

---

Drug Interactions

Allopurinol

Concomitant allopurinol may increase the likelihood of ampicillin-associated skin rash.

Probenecid

Probenecid inhibits renal tubular secretion of ampicillin.

Result:

↑ Ampicillin plasma concentration and prolonged exposure.

Methotrexate

Penicillins may decrease renal elimination of methotrexate and potentially increase:

Methotrexate exposure → methotrexate toxicity.

This interaction is clinically important, particularly with high-dose or otherwise high-risk methotrexate therapy.

Anticoagulants

Broad-spectrum penicillins, including ampicillin, may be associated with changes in INR in patients receiving oral anticoagulants.

Clinical monitoring of INR is appropriate when clinically indicated, particularly after starting or stopping antibacterial therapy.

Aminoglycosides

Ampicillin may be combined therapeutically with aminoglycosides in selected serious infections.

However, certain parenteral products should not be mixed in the same syringe, IV container, or giving set with an aminoglycoside, because physical incompatibility/loss of aminoglycoside activity can occur.

Bacteriostatic antibiotics

Bacteriostatic agents may theoretically interfere with the bactericidal effect of β-lactams in some circumstances. The clinical significance depends on the infection and combination.

Oral typhoid vaccine

Antibacterial therapy can reduce or abolish the effectiveness of the live oral typhoid vaccine.

The supplied source specifically identifies this interaction.

Hormonal contraceptives

Historical product information warns that broad-spectrum antibacterials may potentially reduce the effectiveness of oral hormonal contraceptives, although the evidence for a clinically important interaction is limited and inconsistent.

The supplied document appropriately describes the risk as probably small.

---

Side Effects

Common / relatively common

• Nausea
• Vomiting
• Diarrhea
• Skin rash

Hypersensitivity reactions

• Urticaria
• Pruritus
• Maculopapular rash
• Angioedema
• Fever
• Serum sickness-like reactions
• Anaphylaxis

Gastrointestinal

• Diarrhea
• Antibiotic-associated colitis
• C. difficile-associated diarrhea/colitis

Hematological — uncommon/rare

• Leukopenia
• Thrombocytopenia
• Hemolytic anemia
• Coagulation abnormalities

Renal

Rarely:

• Interstitial nephritis

Neurological

Rarely, particularly with excessive exposure or renal impairment:

• Encephalopathy
• Convulsions/seizures
• Neurotoxicity

The supplied document lists hypersensitivity reactions, GI symptoms, angioedema, anaphylaxis, serum sickness-like reactions, CNS toxicity, interstitial nephritis, hemolytic anemia, leukopenia, thrombocytopenia, coagulation disorders, and antibiotic-associated diarrhea/colitis.

---

Use in Special Populations

Pregnancy

Available evidence does not indicate that penicillins such as ampicillin are major human teratogens.

Ampicillin can cross the placenta.

Pregnancy alone is not generally considered a contraindication when ampicillin is clinically indicated.

The older U.S. labeling classified penicillin pregnancy risk as Category B under the former FDA system; this letter-category system has since been abandoned in favor of narrative risk assessment.

Therefore, modern documentation should not describe ampicillin simply as "FDA pregnancy category B" without explaining that the old classification system has been replaced.

Breastfeeding

Ampicillin passes into breast milk in small/trace amounts.

Clinically important effects in breastfed infants are generally uncommon, but possible effects include:

• Sensitization
• Diarrhea
• Alteration of intestinal flora
• Rare allergic reactions

The supplied document states that only trace amounts enter milk.

Neonates

Ampicillin is frequently used in neonatal medicine when clinically indicated.

However, neonatal renal function is immature, resulting in slower elimination and potentially prolonged half-life.

Therefore, neonatal dosing must be weight-, age-, gestation-, and renal-function adjusted.

The supplied source specifically notes prolonged half-life in neonates.

Children

Ampicillin can be used in children when clinically indicated.

Pediatric dosing should be based on:

• Body weight
• Age
• Infection/site
• Severity
• Renal function
• Suspected organism
• Susceptibility

The older supplied document gives "half the adult dose" for children under 10 years in some general indications. This should not be used as a modern universal pediatric dosing rule, because contemporary pediatric antimicrobial dosing is generally weight-based and indication-specific.

Older adults

No specific age-based contraindication exists, but renal function should be considered because renal clearance may decrease with age.

---

Storage Conditions

The supplied Egyptian information states:

Store at a temperature not exceeding 30°C.

Keep out of the reach of children.

The exact storage requirements of reconstituted oral suspension and reconstituted injection are product-specific and should be taken from the current manufacturer's leaflet.

For example, one current professional injection SmPC states that, from a microbiological perspective, a reconstituted solution should generally be used immediately; if it is not, the responsibility for in-use storage lies with the user and would normally not exceed 24 hours at 2–8°C.

Therefore, do not generalize this 24-hour rule to every ampicillin product.

---

Additional Sections

Antimicrobial Stewardship

Ampicillin should not be used simply because an infection appears bacterial.

Appropriate use requires consideration of:

1. The likely pathogen.
2. Local resistance patterns.
3. Site of infection.
4. Severity of disease.
5. Previous microbiological results.
6. Antibiotic susceptibility testing when available.
7. Renal function.
8. Previous β-lactam allergy.

This is particularly important because resistance to ampicillin is common among several organisms historically considered susceptible.

---

Ampicillin vs. Amoxicillin

Ampicillin and amoxicillin are closely related aminopenicillins, but they are not interchangeable on a milligram-for-milligram basis.

One major practical difference is oral absorption:

• Ampicillin: oral absorption is affected by food; administration on an empty stomach is traditionally recommended.
• Amoxicillin: oral absorption is much better and is not significantly impaired by food.

Therefore, instructions such as "take with food" or "food does not matter" for amoxicillin should not automatically be transferred to oral ampicillin.

---

Ampicillin vs. Ampicillin/Sulbactam

Ampicillin alone is vulnerable to β-lactamase enzymes.

Ampicillin/sulbactam combines ampicillin with the β-lactamase inhibitor sulbactam and consequently has a different spectrum.

They should therefore be considered different antimicrobial products, not simply different brands of the same drug.

---

Important Clinical Resistance Point

The older supplied document states that nearly all staphylococci, approximately 50% of E. coli, and approximately 15% of H. influenzae strains were resistant at the time of publication.

Those exact percentages are historical and should not be presented as current Egyptian resistance rates.

Current resistance is geographically and temporally variable. Therefore, modern clinical decisions should rely on current local antibiograms and susceptibility testing rather than reproducing those historical percentages.

---

Frequently Asked Questions (FAQ)

1. Is ampicillin a penicillin?

Yes. Ampicillin is a semi-synthetic aminopenicillin, belonging to the β-lactam antibiotic family.

2. Is ampicillin bactericidal?

Yes. It kills susceptible bacteria primarily by inhibiting bacterial cell-wall synthesis.

3. Can ampicillin be taken with food?

Oral ampicillin is traditionally recommended on an empty stomach, because food can reduce absorption. The supplied information recommends administration at least 30 minutes before meals.

4. Is ampicillin safe during pregnancy?

When clinically indicated, ampicillin can be used during pregnancy. Available evidence does not indicate a major teratogenic signal, but treatment should always be based on clinical necessity.

5. Can a breastfeeding mother take ampicillin?

Ampicillin enters breast milk in small amounts. Breastfeeding is generally possible when the drug is clinically indicated, while observing the infant for gastrointestinal disturbance or allergic sensitization.

6. Does ampicillin interact with methotrexate?

Yes. Penicillins may reduce methotrexate renal elimination and increase the risk of methotrexate toxicity.

7. Does ampicillin interact with allopurinol?

Yes. Concurrent use may increase the likelihood of an ampicillin-associated skin rash.

8. Why does ampicillin cause a rash in infectious mononucleosis?

Patients with infectious mononucleosis have a markedly increased likelihood of developing a characteristic maculopapular eruption after exposure to aminopenicillins such as ampicillin.

This rash should not automatically be interpreted as proof of IgE-mediated penicillin allergy.

9. Is ampicillin effective against Staphylococcus aureus?

Usually not reliably.

Most contemporary S. aureus isolates produce penicillinase and are therefore resistant to ampicillin.

10. Is ampicillin useful against Listeria?

Yes. Ampicillin is an important first-line agent for susceptible Listeria monocytogenes, particularly invasive listeriosis and meningitis.

11. Is ampicillin useful against Enterococcus?

Yes, when the isolate is susceptible. Ampicillin is particularly important for susceptible E. faecalis infections.

12. Does renal impairment matter?

Yes. Ampicillin is predominantly renally eliminated. Significant renal impairment can prolong its half-life and increase toxicity risk, so dosing intervals and/or doses may need adjustment.

13. Can ampicillin cause seizures?

Rarely. The risk is particularly relevant with high doses and significant renal impairment, where accumulation can occur.

14. Can ampicillin cause diarrhea?

Yes. Diarrhea is a recognized adverse effect. More serious antibiotic-associated diarrhea, including C. difficile-associated colitis, can also occur.

15. Can ampicillin be used for viral infections?

No. Ampicillin does not treat viral infections such as uncomplicated viral upper respiratory infections or influenza.

16. Are all Egyptian ampicillin products identical?

They contain the same active antibacterial ingredient, but strength, dosage form, excipients, packaging, manufacturer, reconstitution requirements, and regulatory details can differ.

The current product-specific leaflet should therefore be checked before administration.

17. Can the old Egyptian information be considered fully current?

No.

The supplied document is useful and contains extensive pharmacological information, but some of its dosing recommendations, resistance percentages, product information, and regulatory details are historical. Current professional labeling and contemporary antimicrobial practice should take precedence where they differ.

---

References

1. DailyMed — Ampicillin for Injection, USP, current U.S. labeling; the cited product label was updated June 22, 2026. DailyMed — Ampicillin injection

2. Electronic Medicines Compendium (emc) — Ampicillin 500 mg powder for solution for injection SmPC, updated February 4, 2025. Ampicillin 500 mg Injection SmPC

3. CDC — Caring for Patients with Listeriosis, clinical-care guidance, August 12, 2024. CDC Listeriosis Clinical Care

4. DailyMed — Ampicillin Capsules, prescribing information. DailyMed — Ampicillin capsules

5. PubChem — Ampicillin, molecular and chemical information. PubChem — Ampicillin

6. User-supplied historical Egyptian product document, containing the historical formulations, Egyptian product list, pharmacokinetics, indications, dosage information, warnings, interactions, storage information, and manufacturer details.

---

Disclaimer

This commentary is provided for educational and professional information only. It is not a substitute for the current approved product information, official regulatory documentation, antimicrobial susceptibility testing, or individualized clinical assessment.

We do not guarantee the accuracy, currency or completeness of information regarding medications or medical products, and official sources should be verified before making any decisions. By using this blog, you agree to assume personal responsibility for relying on the information provided.

For any specific ampicillin product, the current package insert/SmPC, current Egyptian regulatory status, exact strength, formulation, manufacturer, Marketing Authorization Holder, reconstitution instructions, and storage conditions should be verified before use.